Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03567551 · ClinicalTrials.gov registry record
Novel Biomarkers of Preeclampsia, Aquaporin, Fatty Acid, and S110B
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 126
- Enrollment target
NCT03567551 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 126 participants.
The verdict
NCT03567551 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 126 participants
- Enrollment target
Study Summary
This is a research study designed to help identify preeclampsia in pregnant women earlier, and possibly lead to better treatment for women preeclampsia.
Interventions
- OTHER Women w/ Preeclampsia w/o Visual Disturbances or Headache
- OTHER Women w/ Preeclampsia w/ Visual Disturbances or Headaches
- OTHER Women w/o Preeclampsia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2017-05-15 |
| Est. Completion | 2021-09-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03567551
The ClinicalTrials.gov registry entry for NCT03567551 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Women w/ Preeclampsia w/o Visual Disturbances or Headache is the first listed.
NCT03567551 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03567551 about?
NCT03567551 is a clinical study titled "Novel Biomarkers of Preeclampsia, Aquaporin, Fatty Acid, and S110B". This is a research study designed to help identify preeclampsia in pregnant women earlier, and possibly lead to better treatment for women preeclampsia.
What is the current status of trial NCT03567551?
This trial is currently completed. The enrollment target is 126 participants. The study started on 2017-05-15. Estimated completion is 2021-09-15.
What interventions are being tested in trial NCT03567551?
The interventions under investigation include: Women w/ Preeclampsia w/o Visual Disturbances or Headache (OTHER), Women w/ Preeclampsia w/ Visual Disturbances or Headaches (OTHER), Women w/o Preeclampsia (OTHER).
Who is sponsoring clinical trial NCT03567551?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.